HC Wainwright Issues Pessimistic Forecast for Rockwell Medical (NASDAQ:RMTI) Stock Price

Rockwell Medical (NASDAQ:RMTI) had its price objective lowered by equities research analysts at HC Wainwright from $9.00 to $7.00 in a report issued on Monday,Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s price target indicates a potential upside of 211.11% from the stock’s current price. HC Wainwright also issued estimates for Rockwell Medical’s Q2 2025 earnings at ($0.01) EPS, Q3 2025 earnings at ($0.01) EPS and Q4 2025 earnings at $0.01 EPS.

A number of other research firms have also weighed in on RMTI. Rodman & Renshaw assumed coverage on shares of Rockwell Medical in a research note on Thursday, November 14th. They set a “buy” rating and a $5.00 price objective for the company. RODMAN&RENSHAW upgraded shares of Rockwell Medical to a “strong-buy” rating in a research note on Thursday, November 14th. Finally, StockNews.com lowered shares of Rockwell Medical from a “buy” rating to a “hold” rating in a research note on Thursday, November 21st.

Rockwell Medical Trading Down 2.6 %

Shares of NASDAQ RMTI opened at $2.25 on Monday. Rockwell Medical has a 1 year low of $1.16 and a 1 year high of $5.15. The stock has a market cap of $72.72 million, a P/E ratio of -45.00 and a beta of 1.50. The firm has a 50-day moving average of $3.46 and a 200 day moving average of $2.66. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.41 and a quick ratio of 2.00.

Institutional Trading of Rockwell Medical

A number of large investors have recently made changes to their positions in the stock. XTX Topco Ltd grew its stake in shares of Rockwell Medical by 45.7% in the third quarter. XTX Topco Ltd now owns 28,455 shares of the company’s stock worth $113,000 after acquiring an additional 8,922 shares during the period. Concurrent Investment Advisors LLC bought a new stake in shares of Rockwell Medical in the third quarter worth approximately $40,000. Verus Capital Partners LLC bought a new stake in shares of Rockwell Medical in the third quarter worth approximately $51,000. State Street Corp grew its stake in shares of Rockwell Medical by 21.5% in the third quarter. State Street Corp now owns 95,004 shares of the company’s stock worth $377,000 after acquiring an additional 16,800 shares during the period. Finally, Barclays PLC bought a new stake in shares of Rockwell Medical in the third quarter worth approximately $90,000. 23.31% of the stock is currently owned by institutional investors.

Rockwell Medical Company Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.